Cafepharma | Pharmaceutical Sales, Medical Sales, Lab Sales

Cafepharma Today

April 15 2024 - 5 promising MASH therapies that could follow Madrigal’s Rezdiffra

5 promising MASH therapies that could follow Madrigal’s Rezdiffra
Covid vaccines not linked to fatal heart problems in young people, CDC finds
Roche’s Columvi offers survival benefit in Phase III DLBCL trial
Regeneron builds new venture arm with $500M commitment to invest in biotech and beyond
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

AACR: Study Suggests Accelerated Approval Doesn’t Always Lead to Clinical Benefit

BioSpace

Wednesday, April 10, 2024 - 5:44pm

tags:

AACR, oncology, FDA, accelerated approvals

Novartis pauses enrollment in some Kisqali trials to fix manufacturing

BioPharma Dive

Wednesday, April 10, 2024 - 5:28pm

tags:

Novartis, Kisqali, drug manufacturing, breast cancer, clinical trials

The IRA Is Already Curtailing Small Molecule Drug Development. Here’s How to Reverse That.

BioSpace

Wednesday, April 10, 2024 - 11:27am

tags:

small molecule drugs, drug development, Inflation Reduction Act, innovation

7 Billion-Dollar Oncology M&As from Q1

BioSpace

Wednesday, April 10, 2024 - 11:24am

tags:

oncology, M&A, AbbVie, Immunogen, Bristol Myers Squibb, Mirati Therapeutics, RayzeBio, Novartis, MorphoSys, AstraZeneca, Fusion Pharmaceuticals, JNJ, Ambrx, Gracell

AACR: Merck, Kelun’s Anti-TROP2 ADC Shows Early Promise in Gastric Cancer

BioSpace

Wednesday, April 10, 2024 - 9:59am

tags:

Merck, Kelun-Biotech, SKB264, gastric cancer, antibody-drug conjugate, clinical trials, AACR

New Cardiovascular Company Emerges from Stealth Mode

Medical Devices and Diagnostics Industry

Wednesday, April 10, 2024 - 9:57am

tags:

Reprieve Cardiovascular, funding, acute decompensated heart failure

Bristol Myers-backed TORL secures $158M to march army of ADCs through clinic

Fierce Biotech

Wednesday, April 10, 2024 - 9:52am

tags:

Bristol Myers Squibb, TORL BioTherapeutics, antibody-drug conjugate, funding

Invenra, Astellas sign bispecific antibody discovery agreement

Pharmaceutical Business Review

Wednesday, April 10, 2024 - 9:50am

tags:

Astellas, Invenra, B-Body, bispecific antibodies, R&D

GLP-1s Like Novo Nordisk’s Ozempic Do Not Increase Thyroid Cancer Risk: Study

BioSpace

Wednesday, April 10, 2024 - 9:48am

tags:

Novo Nordisk, Ozempic, Victoza, GLP-1 agonist, thyroid cancer

Poor Customer Data Management Costs Pharma Companies Money: Report

BioSpace

Wednesday, April 10, 2024 - 9:27am

tags:

customer data, data management

SpineX eyes FDA submission as neurogenic bladder trial hits milestone

Clinical Trials Arena

Wednesday, April 10, 2024 - 9:23am

tags:

SpineX, neuromodulation, Medtech, clinical trials

Bayer, Google partner on AI for time-pressed radiologists

Pharmaphorum

Wednesday, April 10, 2024 - 9:21am

tags:

Bayer, Google, Google Cloud, artificial intelligence, R&D, radiologists

Birth Control Market Evolves as OTC Opill Hits US Stores

BioSpace

Wednesday, April 10, 2024 - 9:20am

tags:

Perrigo, Opill, OTC, OTC contraceptive pill, contraceptives

Psychiatry drugs finally have pharma’s attention. Can they keep it?

BioPharma Dive

Tuesday, April 9, 2024 - 5:50pm

tags:

Karuna Therapeutics, schizophrenia, psychiatric disease

Philips, maker of millions of defective sleep apnea machines, ordered to overhaul manufacturing

Stat

Tuesday, April 9, 2024 - 5:46pm

tags:

Medtech, Philips, device manufacturing, sleep apnea, DOJ

Biosimilar uptake appears to finally be on the upswing, and Biocon Biologics is betting on the sector’s future

Pharma Voice

Tuesday, April 9, 2024 - 5:45pm

tags:

biosimilars, Biocon

Drug shortages: Study examines pandemic supply chain, HHS proposes resilience incentive

RAPS.org

Tuesday, April 9, 2024 - 5:44pm

tags:

drug shortages, pandemic, COVID-19, HHS

Moderna jumps as vaccine shows benefit in head and neck cancer in early study

Reuters

Tuesday, April 9, 2024 - 5:43pm

tags:

Moderna Therapeutics, Merck, clinical trials, vaccines, head and neck cancer

5 Successful Phase III Oncology Trials in Q1

BioSpace

Tuesday, April 9, 2024 - 11:50am

tags:

oncology, clinical trials, Bristol Myers Squibb, Opdivo, Yervoy, liver cancer, Pfizer, DLBCL, Adcetris, Asieris, HSIL, APL-1702, cervical cancer, Novocure, non-small cell lung cancer, Roche, Genentech, Tecentriq, esophageal squamous cell carcinoma

Karuna's captains set sail in new neuropsychiatric venture called Seaport Therapeutics

Fierce Biotech

Tuesday, April 9, 2024 - 11:43am

tags:

Karuna Therapeutics, Seaport Therapeutics, PureTech Health, funding, anxiety, depression

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition

Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research

First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study

Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth

Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Sapio Sciences launches new drug discovery platform

Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics

Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility

Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

How Patient Engagement Can Reduce Brand Launch Risks

Drug Channels

The Top Pharmacy Benefit Managers of 2023: Market Share and Trends for the Biggest Companies—And What’s Ahead

Drug Channels

SAVE THE DATE: Drug Channels Leadership Forum, March 17-19, 2025

Drug Channels

Tales of the Unsurprised: U.S. Brand-Name Drug Prices Fell for an Unprecedented Sixth Consecutive Year—And Will Fall Further in 2024 (rerun)

Drug Channels

Vertical Integration Lessons: The Economics and Strategies of Hospital-Owned Specialty Pharmacies (rerun)

Drug Channels

The Big Three PBMs’ 2024 Formulary Exclusions: Biosimilar Humira Battles, CVS Health’s Weird Strategy, and the Insulin Shakeup (rerun)

Drug Channels

What CVS Pharmacy’s New Cost-Plus Reimbursement Approach Means for PBMs, Pharmacies, Plan Sponsors, and Prescription Prices (rerun)

Drug Channels

Understanding CVS Health/McKesson and Why Pharmacies Lose Money on GLP-1s (rerun)

Drug Channels

Navigating Market Access Challenges in Life Sciences Commercialization

Drug Channels